At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Axonics SNM System INS Model 5101 (R20) (device)
- How long the study runs
- Study runs about 27 months (dates as stated)
- About the drug or intervention
- Axonics SNM System INS Model 5101 (R20) — device: Participants treated with the rechargeable Axonics SNM System Model 5101 also referred to as R20.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 55
- Started
- 2025-09-18
- Last checked
- 2026-09
Plain English Summary
What is this study?
- • Testing a new treatment for urinary urge incontinence (uui)
- • NA - 55 participants
- • Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with urinary urge incontinence (uui)
Where?
- • Bradford - Bradford Royal Infirmary
- • Wakefield - Pinderfields Hospital
- • Leeds - St James's University Hospital
- • London - University College London Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.
More detail
This post-market clinical follow-up (PMCF) is conducted to assess the continued safety, device performance, and clinical benefit of the rechargeable Axonics SNM System INS Model 5101 also referred to as R20.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
Biomarkers mentioned
What the study is looking for
- ✓18 years or older
- ✓Primary indication of OAB (urinary urgency incontinence (UUI) / urinary frequency (UF) who are not candidates for,...
- ✓Willing and capable to provide written consent and agrees to comply with specified evaluations at clinical centers...
Who cannot take part
- ✗History of allergic response to titanium, zirconia, polyurethane, epoxy, or silicone
- ✗A female who is breastfeeding
- ✗A female with a positive urine pregnancy test
See the full criteria
Where Is This Study? (4 UK sites)
Bradford Royal Infirmary
Bradford BD96RJ, United Kingdom
Pinderfields Hospital
Wakefield WF1 4DG, United Kingdom
St James's University Hospital
Leeds, United Kingdom
University College London Hospital
London W1G 8PH, United Kingdom
How to Get in Touch
Caroline Beaudoint
Sponsor contactCONTACT
Erum Shaikh
Sponsor contactCONTACT
